GlyNAC supplementation improves cognitive decline in older people

Washington [US], May 7: Age-related cognitive decline is a natural part of ageing, and as people get older, they strive to lead healthy lives as free as possible from it. At Baylor College of Medicine, scientists have been researching the molecular causes of age-related cognitive loss and creating dietary plans to encourage healthy brain ageing.

In a study published in the journal Antioxidants, researchers found that supplementing with GlyNAC, a compound made up of the amino acids glycine and N-acetylcysteine, which act as precursors to the naturally occurring antioxidant glutathione, improved or reversed age-related cognitive decline in old mice and corrected multiple associated defects in the ageing brain. The results are in line with improvements seen after giving older persons GlyNAC supplements, as reported in their 2021 pilot human experiment; as a result, “For over two decades, my lab has been studying natural aging in older humans and aged mice,” said corresponding and senior author Dr. Rajagopal Sekhar, professor of medicine -endocrinology, diabetes and metabolism at Baylor. “Our work provides an understanding of how age-associated cognitive decline in older humans is linked to glutathione deficiency, increased oxidative stress, mitochondrial dysfunction, abnormal glucose metabolism and insulin resistance, inflammation and low levels of neurotrophic or neuron-supporting factors, and that supplementing GlyNAC reverses these defects and improves cognition.”

Human studies only permit measurements at the whole-body level, so in this study the researchers studied mice to investigate defects directly in the aging brain.

This study is important for many reasons: it assesses the reversibility of naturally occurring cognitive decline in aging instead of cognitive decline resulting from introducing gene defects; increased age is identified as the most important risk factor for Alzheimer’s disease; and these naturally occurring defects were studied directly in the brain.

Sekhar and his team worked with three groups of mice. Two groups were aged naturally side-by-side until they were 90 weeks old, which is similar to a 70-year-old person. At 90 weeks of age, both groups of old mice were evaluated for their cognitive abilities, such as remembering the correct route in a maze that leads to a food reward. These results were compared to those of young mice, the third group. Then, one group of old mice began a GlyNAC-supplemented diet, while the other group, called the old-controls, continued their regular diet without GlyNAC supplementation.

After completing eight weeks on their respective diets, the animals’ cognitive abilities were evaluated again and their brains analyzed to measure specific brain defects that had previously been associated with cognitive impairment in studies by others. The results of these analyses in old mice supplemented with GlyNAC were compared with those of the old-control group and with the corresponding data obtained from young mice.